Systematic review of incretin therapy during peri-operative and intensive care

Systematic review of incretin therapy during peri-operative and intensive care

Abstract Background Glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic peptide (GIP) are incretin hormones. By lowering blood glucose in a glucose-dependent manner, incretin-based therapies represent a novel and promising intervention to treat hyperglycaemia in hospital settings. W...

Full description

Bibliographic Details
Main Authors: Abraham H Hulst, Mark P Plummer, Markus W Hollmann, J Hans DeVries, Benedikt Preckel, Adam M Deane, Jeroen Hermanides
Format: Article
Language:English
Published: BMC 2018-11-01
Series:Critical Care
Subjects:
DPP-IV inhibitors
GIP
GLP-1
Glucose control
Hyperglycaemia
Hypoglycaemia
Online Access:http://link.springer.com/article/10.1186/s13054-018-2197-4

Internet

http://link.springer.com/article/10.1186/s13054-018-2197-4

Similar Items